» Articles » PMID: 32851511

Cinnamaldehyde Attenuates the Progression of Rheumatoid Arthritis Through Down-Regulation of PI3K/AKT Signaling Pathway

Overview
Journal Inflammation
Date 2020 Aug 28
PMID 32851511
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Cinnamaldehyde (CA), as an active compound isolated from the bark of Cinnamomum cassia, has been reported to possess the anti-fungal, anti-bacterial, anti-inflammatory, anti-mutagenic, and anti-oxidant properties. However, the possible effects and underlying mechanisms of CA on rheumatoid arthritis (RA) have not been revealed yet. In the present study, we found that CA obviously improved the type II collagen-induced RA in rats, accompanied with decreasing pro-inflammatory factors, proliferation and metastasis. In addition, CA decreased the expression levels of TNF-α, IL-1β, and IL-6 in RA-FLSs. Besides, CA remarkably inhibited the proliferation, downregulated the EdU-positive cells, and promoted apoptosis of RA-FLSs by CCK-8, EdU and flow cytometry analysis. Moreover, the results of wound healing, transwell migration and invasion assays showed that CA inhibited the migration and invasion of RA-FLSs. Further, western blot experiment showed CA inhibited the activation of PI3K/AKT signaling pathway in RA-FLSs. Finally, 740Y-P, the PI3K/AKT signaling pathway activator, could reverse the effects of CA on the proliferation and metastasis in RA-FLSs. In conclusion, we confirmed that CA exhibited potential therapeutic properties against RA via suppressing proliferation and metastasis of RA-FLSs by blockage of PI3K/AKT signaling pathway. Therefore, our study provides evidence that CA may emerge as a therapeutic option for RA treatment.

Citing Articles

Pharmacological modes of plant-derived compounds for targeting inflammation in rheumatoid arthritis: A comprehensive review on immunomodulatory perspective.

Nazakat L, Ali S, Summer M, Nazakat F, Noor S, Riaz A Inflammopharmacology. 2025; .

PMID: 40074996 DOI: 10.1007/s10787-025-01664-7.


Levamisole Ameliorates Rheumatoid Arthritis by Downregulating the PI3K/Akt Pathway in SD Rats.

Guo M, Yu X, Yang Z, Zheng H, Zhang J, Wang J Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598415 PMC: 11597538. DOI: 10.3390/ph17111504.


Advances in pharmacological effects and mechanism of action of cinnamaldehyde.

Guo J, Yan S, Jiang X, Su Z, Zhang F, Xie J Front Pharmacol. 2024; 15:1365949.

PMID: 38903995 PMC: 11187351. DOI: 10.3389/fphar.2024.1365949.


Salidroside suppresses cell growth and inflammatory response of fibroblast-like synoviocytes via inhibition of phosphoinositol-3 kinase/threonine kinase signaling in rheumatoid arthritis.

Qin Y, Su J Z Rheumatol. 2023; 83(Suppl 1):78-87.

PMID: 37851166 DOI: 10.1007/s00393-023-01431-5.


Advances of the small molecule drugs regulating fibroblast-like synovial proliferation for rheumatoid arthritis.

Tong Y, Li X, Deng Q, Shi J, Feng Y, Bai L Front Pharmacol. 2023; 14:1230293.

PMID: 37547337 PMC: 10400780. DOI: 10.3389/fphar.2023.1230293.


References
1.
Scott D, Wolfe F, Huizinga T . Rheumatoid arthritis. Lancet. 2010; 376(9746):1094-108. DOI: 10.1016/S0140-6736(10)60826-4. View

2.
Wasserman A . Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2011; 84(11):1245-52. View

3.
Allard-Chamard H, Boire G . Serologic Diagnosis of Rheumatoid Arthritis. Clin Lab Med. 2019; 39(4):525-537. DOI: 10.1016/j.cll.2019.07.002. View

4.
Mian A, Ibrahim F, Scott D . A systematic review of guidelines for managing rheumatoid arthritis. BMC Rheumatol. 2019; 3:42. PMC: 6805606. DOI: 10.1186/s41927-019-0090-7. View

5.
Bustamante M, Garcia-Carbonell R, Whisenant K, Guma M . Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017; 19(1):110. PMC: 5452638. DOI: 10.1186/s13075-017-1303-3. View